Regulation of blood pressure is influenced by gender: A study in obese Zucker rats

The present study determined the role of renin-angiotensin system (RAS), endothelin system, and eicosanoid system in the blood pressure (BP) regulation in male and female Zucker rats, and whether the pressor response change similarly in lean and obese animals. In female (f) and male (m), lean (L) an...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Life sciences (1973) 2018-09, Vol.209, p.236-241
Hauptverfasser: Moulana, Mohadetheh, Maranon, Rodrigo O.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 241
container_issue
container_start_page 236
container_title Life sciences (1973)
container_volume 209
creator Moulana, Mohadetheh
Maranon, Rodrigo O.
description The present study determined the role of renin-angiotensin system (RAS), endothelin system, and eicosanoid system in the blood pressure (BP) regulation in male and female Zucker rats, and whether the pressor response change similarly in lean and obese animals. In female (f) and male (m), lean (L) and obese (O) Zucker rats (ZR) at 22 weeks old, we evaluated the role of the 3 mentioned systems using the following treatments: 1) enalapril (angiotensin I converting enzyme inhibitor), 2) the ABT-627 (endothelin receptor A (ETA) antagonist), and 3) the 1-aminobenzotriazol (1-ABT: eicosanoid synthesis inhibitor). MAP by radiotelemetry was similar and significantly higher in mOZR (120 ± 2 mm Hg) and fOZR (116 ± 4 mm Hg) (p 
doi_str_mv 10.1016/j.lfs.2018.08.020
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6639019</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0024320518304661</els_id><sourcerecordid>2087591309</sourcerecordid><originalsourceid>FETCH-LOGICAL-c479t-a149ec5059ba48f1cd839b0fce20ab2f538953ee37c49836226b2b0913fbdb353</originalsourceid><addsrcrecordid>eNp9kU2LFDEQhoMo7rj6A7xIwIuXHitJpztREJbFL1gQFr14CUm6eszY0xmTzsL8ezPOuqgHoaAO9dRbHy8hTxmsGbDu5XY9jXnNgak11OBwj6yY6nUDnWD3yQqAt43gIM_Io5y3ACBlLx6SMwGglWjFilxf46ZMdglxpnGkbopxoPuEOZeENGQa5nEqOHscqDvQDc4Dplf0gualDIdapdFhRvq1-O-YaLJLfkwejHbK-OQ2n5Mv795-vvzQXH16__Hy4qrxba-XxrJWo5cgtbOtGpkflNAORo8crOOjFEpLgSh639ZlO847xx1oJkY3OCHFOXlz0t0Xt8PB47wkO5l9CjubDibaYP6uzOGb2cQb03VCA9NV4MWtQIo_CubF7EL2OE12xliy4aB6WefBEX3-D7qNJc31PMMZU0J1UohKsRPlU8w54Xi3DANzdMxsTXXMHB0zUIND7Xn25xV3Hb8tqsDrE4D1lzcBk8k-_DIkJPSLGWL4j_xPr52mpQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2118386533</pqid></control><display><type>article</type><title>Regulation of blood pressure is influenced by gender: A study in obese Zucker rats</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Moulana, Mohadetheh ; Maranon, Rodrigo O.</creator><creatorcontrib>Moulana, Mohadetheh ; Maranon, Rodrigo O.</creatorcontrib><description><![CDATA[The present study determined the role of renin-angiotensin system (RAS), endothelin system, and eicosanoid system in the blood pressure (BP) regulation in male and female Zucker rats, and whether the pressor response change similarly in lean and obese animals. In female (f) and male (m), lean (L) and obese (O) Zucker rats (ZR) at 22 weeks old, we evaluated the role of the 3 mentioned systems using the following treatments: 1) enalapril (angiotensin I converting enzyme inhibitor), 2) the ABT-627 (endothelin receptor A (ETA) antagonist), and 3) the 1-aminobenzotriazol (1-ABT: eicosanoid synthesis inhibitor). MAP by radiotelemetry was similar and significantly higher in mOZR (120 ± 2 mm Hg) and fOZR (116 ± 4 mm Hg) (p < 0.05 vs. m-, fLZR), than mLZR (105 ± 3 mm Hg) and fLZR (106 ± 1 mm Hg), that were also similar. Enalapril reduced MAP more in mOZR (23%) and mLZR (26%), than fLZR (20%, p < 0.905 vs. mLZR) or fOZR (9%; p < 0.05 vs. other groups). After 10 days of drug-free and recovery period, ABT-627 reduced MAP in fLZR and mLZR by similar amounts (102 ± 4 to 92 ± 3 mm Hg, n = 6; p < 0.05 and 105 ± 2 vs. 92 ± 3 mm Hg, n = 6; p < 0.05, respectively), but did not affect either fOZR or mOZR. After another 10 days of drug-free and recovery period, 1-ABT reduced MAP in fOZR (116 ± 4 to 95 ± 2, n = 6; p < 0.05), and did not affect all other groups. We show that the mechanisms responsible for elevated BP in male and female OZR and LZR are different, and suggest that obesity may cause an increase in BP via different mechanisms in men and women as well.]]></description><identifier>ISSN: 0024-3205</identifier><identifier>EISSN: 1879-0631</identifier><identifier>DOI: 10.1016/j.lfs.2018.08.020</identifier><identifier>PMID: 30098343</identifier><language>eng</language><publisher>Netherlands: Elsevier Inc</publisher><subject>20-HETE ; Angiotensin ; Angiotensin I ; Angiotensin-Converting Enzyme Inhibitors - therapeutic use ; Animals ; Blood pressure ; Blood Pressure - drug effects ; Blood Pressure - physiology ; Cardiovascular Diseases - etiology ; Cardiovascular Diseases - prevention &amp; control ; Endothelin ; Endothelins ; Enzyme inhibitors ; Female ; Hypertension ; Life sciences ; Male ; Obesity ; Obesity - physiopathology ; Rats ; Rats, Zucker ; Recovery ; Renin ; Renin-angiotensin system ; Renin-Angiotensin System - drug effects ; Rodents ; Sex Factors</subject><ispartof>Life sciences (1973), 2018-09, Vol.209, p.236-241</ispartof><rights>2018</rights><rights>Published by Elsevier Inc.</rights><rights>Copyright Elsevier BV Sep 15, 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c479t-a149ec5059ba48f1cd839b0fce20ab2f538953ee37c49836226b2b0913fbdb353</citedby><cites>FETCH-LOGICAL-c479t-a149ec5059ba48f1cd839b0fce20ab2f538953ee37c49836226b2b0913fbdb353</cites><orcidid>0000-0002-3743-7420</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.lfs.2018.08.020$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,780,784,885,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30098343$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Moulana, Mohadetheh</creatorcontrib><creatorcontrib>Maranon, Rodrigo O.</creatorcontrib><title>Regulation of blood pressure is influenced by gender: A study in obese Zucker rats</title><title>Life sciences (1973)</title><addtitle>Life Sci</addtitle><description><![CDATA[The present study determined the role of renin-angiotensin system (RAS), endothelin system, and eicosanoid system in the blood pressure (BP) regulation in male and female Zucker rats, and whether the pressor response change similarly in lean and obese animals. In female (f) and male (m), lean (L) and obese (O) Zucker rats (ZR) at 22 weeks old, we evaluated the role of the 3 mentioned systems using the following treatments: 1) enalapril (angiotensin I converting enzyme inhibitor), 2) the ABT-627 (endothelin receptor A (ETA) antagonist), and 3) the 1-aminobenzotriazol (1-ABT: eicosanoid synthesis inhibitor). MAP by radiotelemetry was similar and significantly higher in mOZR (120 ± 2 mm Hg) and fOZR (116 ± 4 mm Hg) (p < 0.05 vs. m-, fLZR), than mLZR (105 ± 3 mm Hg) and fLZR (106 ± 1 mm Hg), that were also similar. Enalapril reduced MAP more in mOZR (23%) and mLZR (26%), than fLZR (20%, p < 0.905 vs. mLZR) or fOZR (9%; p < 0.05 vs. other groups). After 10 days of drug-free and recovery period, ABT-627 reduced MAP in fLZR and mLZR by similar amounts (102 ± 4 to 92 ± 3 mm Hg, n = 6; p < 0.05 and 105 ± 2 vs. 92 ± 3 mm Hg, n = 6; p < 0.05, respectively), but did not affect either fOZR or mOZR. After another 10 days of drug-free and recovery period, 1-ABT reduced MAP in fOZR (116 ± 4 to 95 ± 2, n = 6; p < 0.05), and did not affect all other groups. We show that the mechanisms responsible for elevated BP in male and female OZR and LZR are different, and suggest that obesity may cause an increase in BP via different mechanisms in men and women as well.]]></description><subject>20-HETE</subject><subject>Angiotensin</subject><subject>Angiotensin I</subject><subject>Angiotensin-Converting Enzyme Inhibitors - therapeutic use</subject><subject>Animals</subject><subject>Blood pressure</subject><subject>Blood Pressure - drug effects</subject><subject>Blood Pressure - physiology</subject><subject>Cardiovascular Diseases - etiology</subject><subject>Cardiovascular Diseases - prevention &amp; control</subject><subject>Endothelin</subject><subject>Endothelins</subject><subject>Enzyme inhibitors</subject><subject>Female</subject><subject>Hypertension</subject><subject>Life sciences</subject><subject>Male</subject><subject>Obesity</subject><subject>Obesity - physiopathology</subject><subject>Rats</subject><subject>Rats, Zucker</subject><subject>Recovery</subject><subject>Renin</subject><subject>Renin-angiotensin system</subject><subject>Renin-Angiotensin System - drug effects</subject><subject>Rodents</subject><subject>Sex Factors</subject><issn>0024-3205</issn><issn>1879-0631</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU2LFDEQhoMo7rj6A7xIwIuXHitJpztREJbFL1gQFr14CUm6eszY0xmTzsL8ezPOuqgHoaAO9dRbHy8hTxmsGbDu5XY9jXnNgak11OBwj6yY6nUDnWD3yQqAt43gIM_Io5y3ACBlLx6SMwGglWjFilxf46ZMdglxpnGkbopxoPuEOZeENGQa5nEqOHscqDvQDc4Dplf0gualDIdapdFhRvq1-O-YaLJLfkwejHbK-OQ2n5Mv795-vvzQXH16__Hy4qrxba-XxrJWo5cgtbOtGpkflNAORo8crOOjFEpLgSh639ZlO847xx1oJkY3OCHFOXlz0t0Xt8PB47wkO5l9CjubDibaYP6uzOGb2cQb03VCA9NV4MWtQIo_CubF7EL2OE12xliy4aB6WefBEX3-D7qNJc31PMMZU0J1UohKsRPlU8w54Xi3DANzdMxsTXXMHB0zUIND7Xn25xV3Hb8tqsDrE4D1lzcBk8k-_DIkJPSLGWL4j_xPr52mpQ</recordid><startdate>20180915</startdate><enddate>20180915</enddate><creator>Moulana, Mohadetheh</creator><creator>Maranon, Rodrigo O.</creator><general>Elsevier Inc</general><general>Elsevier BV</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-3743-7420</orcidid></search><sort><creationdate>20180915</creationdate><title>Regulation of blood pressure is influenced by gender: A study in obese Zucker rats</title><author>Moulana, Mohadetheh ; Maranon, Rodrigo O.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c479t-a149ec5059ba48f1cd839b0fce20ab2f538953ee37c49836226b2b0913fbdb353</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>20-HETE</topic><topic>Angiotensin</topic><topic>Angiotensin I</topic><topic>Angiotensin-Converting Enzyme Inhibitors - therapeutic use</topic><topic>Animals</topic><topic>Blood pressure</topic><topic>Blood Pressure - drug effects</topic><topic>Blood Pressure - physiology</topic><topic>Cardiovascular Diseases - etiology</topic><topic>Cardiovascular Diseases - prevention &amp; control</topic><topic>Endothelin</topic><topic>Endothelins</topic><topic>Enzyme inhibitors</topic><topic>Female</topic><topic>Hypertension</topic><topic>Life sciences</topic><topic>Male</topic><topic>Obesity</topic><topic>Obesity - physiopathology</topic><topic>Rats</topic><topic>Rats, Zucker</topic><topic>Recovery</topic><topic>Renin</topic><topic>Renin-angiotensin system</topic><topic>Renin-Angiotensin System - drug effects</topic><topic>Rodents</topic><topic>Sex Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Moulana, Mohadetheh</creatorcontrib><creatorcontrib>Maranon, Rodrigo O.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Life sciences (1973)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Moulana, Mohadetheh</au><au>Maranon, Rodrigo O.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Regulation of blood pressure is influenced by gender: A study in obese Zucker rats</atitle><jtitle>Life sciences (1973)</jtitle><addtitle>Life Sci</addtitle><date>2018-09-15</date><risdate>2018</risdate><volume>209</volume><spage>236</spage><epage>241</epage><pages>236-241</pages><issn>0024-3205</issn><eissn>1879-0631</eissn><abstract><![CDATA[The present study determined the role of renin-angiotensin system (RAS), endothelin system, and eicosanoid system in the blood pressure (BP) regulation in male and female Zucker rats, and whether the pressor response change similarly in lean and obese animals. In female (f) and male (m), lean (L) and obese (O) Zucker rats (ZR) at 22 weeks old, we evaluated the role of the 3 mentioned systems using the following treatments: 1) enalapril (angiotensin I converting enzyme inhibitor), 2) the ABT-627 (endothelin receptor A (ETA) antagonist), and 3) the 1-aminobenzotriazol (1-ABT: eicosanoid synthesis inhibitor). MAP by radiotelemetry was similar and significantly higher in mOZR (120 ± 2 mm Hg) and fOZR (116 ± 4 mm Hg) (p < 0.05 vs. m-, fLZR), than mLZR (105 ± 3 mm Hg) and fLZR (106 ± 1 mm Hg), that were also similar. Enalapril reduced MAP more in mOZR (23%) and mLZR (26%), than fLZR (20%, p < 0.905 vs. mLZR) or fOZR (9%; p < 0.05 vs. other groups). After 10 days of drug-free and recovery period, ABT-627 reduced MAP in fLZR and mLZR by similar amounts (102 ± 4 to 92 ± 3 mm Hg, n = 6; p < 0.05 and 105 ± 2 vs. 92 ± 3 mm Hg, n = 6; p < 0.05, respectively), but did not affect either fOZR or mOZR. After another 10 days of drug-free and recovery period, 1-ABT reduced MAP in fOZR (116 ± 4 to 95 ± 2, n = 6; p < 0.05), and did not affect all other groups. We show that the mechanisms responsible for elevated BP in male and female OZR and LZR are different, and suggest that obesity may cause an increase in BP via different mechanisms in men and women as well.]]></abstract><cop>Netherlands</cop><pub>Elsevier Inc</pub><pmid>30098343</pmid><doi>10.1016/j.lfs.2018.08.020</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0002-3743-7420</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0024-3205
ispartof Life sciences (1973), 2018-09, Vol.209, p.236-241
issn 0024-3205
1879-0631
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6639019
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects 20-HETE
Angiotensin
Angiotensin I
Angiotensin-Converting Enzyme Inhibitors - therapeutic use
Animals
Blood pressure
Blood Pressure - drug effects
Blood Pressure - physiology
Cardiovascular Diseases - etiology
Cardiovascular Diseases - prevention & control
Endothelin
Endothelins
Enzyme inhibitors
Female
Hypertension
Life sciences
Male
Obesity
Obesity - physiopathology
Rats
Rats, Zucker
Recovery
Renin
Renin-angiotensin system
Renin-Angiotensin System - drug effects
Rodents
Sex Factors
title Regulation of blood pressure is influenced by gender: A study in obese Zucker rats
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T03%3A35%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Regulation%20of%20blood%20pressure%20is%20influenced%20by%20gender:%20A%20study%20in%20obese%20Zucker%20rats&rft.jtitle=Life%20sciences%20(1973)&rft.au=Moulana,%20Mohadetheh&rft.date=2018-09-15&rft.volume=209&rft.spage=236&rft.epage=241&rft.pages=236-241&rft.issn=0024-3205&rft.eissn=1879-0631&rft_id=info:doi/10.1016/j.lfs.2018.08.020&rft_dat=%3Cproquest_pubme%3E2087591309%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2118386533&rft_id=info:pmid/30098343&rft_els_id=S0024320518304661&rfr_iscdi=true